Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
Hlavní autoři: | Flossmann, O, Jones, R, Jayne, DR, Luqmani, R |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2006
|
Podobné jednotky
-
Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
Autor: Mukhtyar, C, a další
Vydáno: (2006) -
Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
Autor: Mukhtyar, C, a další
Vydáno: (2008) -
Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
Autor: Saket Jha, a další
Vydáno: (2019-01-01) -
Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
Autor: Zhi-Ying Li, a další
Vydáno: (2020-08-01) -
A Case of Postcoronavirus Disease 2019 Antineutrophil Cytoplasmic Antibody-associated Vasculitis Successfully Treated with Rituximab
Autor: Mahmoud M. Mohamed, a další
Vydáno: (2023-07-01)